In Brief This Week: Becton Dickinson, Corning; Empire Genomics; Emergent Technologies; Octa Phillip Bioscience Managers | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson this week completed the sale of its Discovery Labware business to Corning for approximately $720 million in cash. The sale excludes BD's Advanced Bioprocessing platform.


Empire Genomics has opened a new clinical lab facility at its headquarters on the Buffalo Niagara Medical Campus in upstate New York and expects to create more than 50 new jobs within the next five years. The firm also introduced this week its multiple myeloma test for aiding physicians in therapeutic guidance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.